Fig. 4From: Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinomaExternal validation of the risk predictive model in the ICGC and GSE14520. A, B The time-dependent ROC analysis and Kaplan-Meier survival analysis for predicting the overall survival of patients using the risk score in the ICGC cohort. C, D The time-dependent ROC analysis and Kaplan-Meier survival analysis for predicting the overall survival of patients using the risk score in the GSE14520. E Distribution of the risk score. F Survival status of patientsBack to article page